A rift between Moderna and the US government deepened on Thursday after the biotech group dismissed claims by the National Institutes of Health that three of its scientists should be recognised as co-inventors of a patent underpinning the company’s Covid-19 vaccine.
More than any other vaccine maker, Moderna has worked in lockstep with the US government to develop its jab, receiving about $2.5bn of grants and orders while also collaborating on clinical trials.
But now the pair are engaged in a bitter dispute over a patent relating to the genetic sequence in the vaccine: the NIH says its scientists are co-inventors, while Moderna insists they are not.
您已阅读17%（659字），剩余83%（3188字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。